Top

Archives of Osteoporosis

Published in:

01-12-2023 | Osteoporosis | Original Article

The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men

Authors: Miaomiao Jin, Renjun Cao, Pengfei Shan, Xiaohong Niu

Published in: Archives of Osteoporosis | Issue 1/2023

Abstract

Summary

Our results suggest that the serum GDF11 concentration is significantly associated with the risk of bone metabolism dysfunction in men and may be a useful target for prediction of osteopenia/osteoporosis to enable prompt intervention for this common but invariably under- or misdiagnosed condition in men.

Purpose

Male osteopenia/osteoporosis remains a neglected subject or is under- or misdiagnosed. Many studies have confirmed the role of growth differentiation factor 11 (GDF11) in bone metabolism, although its role in bone metabolism remains controversial. In this study, we aimed to investigate the association between serum GDF11 levels and the prevalence of osteopenia/osteoporosis (OP) in a male cohort and explore the possibility of GDF11 to be a useful target for prediction of osteopenia/osteoporosis to enable prompt intervention for this disease.

Methods

This cross-sectional study included 121 native Chinese men randomly aged 20–87 years, excluded the subjects who had the conditions of bone metabolism-related disease and administration of hormonal drugs, and grouped the subjects to OP and non-OP, based on the WHO definition and latest guidelines of OP. The serum GDF11 concentration was determined using a GDF11-specific immunoassay. Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry. Tartrate-resistant acid phosphatase 5b (TRAP-5b) were measured in serum samples with ELISA method.

Results

We observed a negative correlation between serum GDF11 levels and age, a positive correlation between serum GDF11 levels and the femoral neck BMD, and a negative correlation between serum GDF11 levels and TRAP-5b in men. The prevalence and risk of OP were significantly higher in men with low serum GDF11 levels.

Conclusions

The serum GDF11 concentration is significantly associated with the risk of bone metabolism dysfunction and may be a useful target for prediction of OP in male cohort.

Anam AK, Insogna K (2021) Update on osteoporosis screening and management. Med Clin North Am 105(6):1117–1134. https://doi.org/10.1016/j.mcna.2021.05.016CrossRefPubMed

Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (London, England) 353(9156):878–882. https://doi.org/10.1016/s0140-6736(98)09075-8CrossRefPubMed

Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390. https://doi.org/10.7326/0003-4819-152-6-201003160-00008CrossRefPubMedPubMedCentral

Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359(9319):1761–1767. https://doi.org/10.1016/s0140-6736(02)08657-9CrossRefPubMed

Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30(4):637–646. https://doi.org/10.1002/jbmr.2393CrossRefPubMed

Porcelli T, Maffezzoni F, Pezzaioli LC, Delbarba A, Cappelli C, Ferlin A (2020) MANAGEMENT OF ENDOCRINE DISEASE: Male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis? Eur J Endocrinol 183(3):R75–r93. https://doi.org/10.1530/eje-20-0034CrossRefPubMed

Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H et al (2013) miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 28(5):1180–1190. https://doi.org/10.1002/jbmr.1845CrossRefPubMed

Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY et al (2014) MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res 29(2):338–347. https://doi.org/10.1002/jbmr.2032CrossRefPubMed

Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y et al (2015) Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene 557(2):209–214. https://doi.org/10.1016/j.gene.2014.12.039CrossRefPubMed

10.

Li Z, Zeng F, Mitchell AD, Kim YS, Wu Z, Yang J (2011) Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation. Biochem Biophys Res Commun 416(3-4):289–292. https://doi.org/10.1016/j.bbrc.2011.11.019CrossRefPubMedPubMedCentral

11.

Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE et al (2015) GDF11 Increases with age and inhibits skeletal muscle regeneration. Cell Metab 22(1):164–174. https://doi.org/10.1016/j.cmet.2015.05.010CrossRefPubMedPubMedCentral

12.

Suh J, Kim NK, Lee SH, Eom JH, Lee Y, Park JC et al (2020) GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone. Proc Natl Acad Sci U S A 117(9):4910–4920. https://doi.org/10.1073/pnas.1916034117CrossRefPubMedPubMedCentral

13.

Jin M, Song S, Guo L, Jiang T, Lin ZY (2016) Increased serum GDF11 concentration is associated with a high prevalence of osteoporosis in elderly native Chinese women. Clin Exp Pharmacol Physiol 43(11):1145–1147. https://doi.org/10.1111/1440-1681.12651CrossRefPubMed

14.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141. https://doi.org/10.1002/jbmr.5650090802CrossRefPubMed

15.

Qaseem A, Forciea MA, McLean RM, Denberg TD, Barry MJ, Cooke M et al (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818–839. https://doi.org/10.7326/m15-1361CrossRefPubMed

16.

Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P et al (2013) Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153(4):828–839. https://doi.org/10.1016/j.cell.2013.04.015CrossRefPubMedPubMedCentral

17.

Hu Z, Yang K, Hu Z, Li M, Wei H, Tang Z et al (2021) Determining the association between hypertension and bone metabolism markers in osteoporotic patients. Medicine 100(24):e26276. https://doi.org/10.1097/md.0000000000026276CrossRefPubMedPubMedCentral

18.

Opstad TB, Kalstad AA, Pettersen A, Arnesen H, Seljeflot I (2019) Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease. Exp Gerontol 119:53–60. https://doi.org/10.1016/j.exger.2019.01.020CrossRefPubMed

19.

Lu B, Zhong J, Pan J, Yuan X, Ren M, Jiang L et al (2019) Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice. J Transl Med 17(1):422. https://doi.org/10.1186/s12967-019-02166-1CrossRefPubMedPubMedCentral

20.

Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S (2010) Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25(5):983–993. https://doi.org/10.1359/jbmr.091104CrossRefPubMed

21.

Khakpour S, Esrafilian A, Tanska P, Mononen ME, Korhonen RK, Jämsä T (2022) Effect of osteoporosis-related reduction in the mechanical properties of bone on the acetabular fracture during a sideways fall: a parametric finite element approach. PLoS One 17(2):e0263458. https://doi.org/10.1371/journal.pone.0263458CrossRefPubMedPubMedCentral

22.

Doi M, Chiba K, Okazaki N, Kondo C, Yamada S, Yokota K et al (2022) Bone microstructure in healthy men measured by HR-pQCT: age-related changes and their relationships with DXA parameters and biochemical markers. Bone 154:116252. https://doi.org/10.1016/j.bone.2021.116252CrossRefPubMed

23.

Zhou Y, Song L, Ni S, Zhang Y, Zhang S (2019) Administration of rGDF11 retards the aging process in male mice via action of anti-oxidant system. Biogerontology 20(4):433–443. https://doi.org/10.1007/s10522-019-09799-1CrossRefPubMed

24.

Añón-Hidalgo J, Catalán V, Rodríguez A, Ramírez B, Silva C, Galofré JC et al (2019) Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes. Aging 11(6):1733–1744. https://doi.org/10.18632/aging.101865CrossRefPubMedPubMedCentral

25.

Bin Z, Yanli Y, Zhen Q, Qingtao M, Zhongyuan X (2020) GDF11 ameliorated myocardial ischemia reperfusion injury by antioxidant stress and up-regulating autophagy in STZ-induced type 1 diabetic rats. Acta Cir Bras 34(11):e201901106. https://doi.org/10.1590/s0102-865020190110000006CrossRefPubMedPubMedCentral

26.

Xu B, Huang Y, Zhang R, Tang M, He Z, Jin L et al (2021) Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort. J Diabetes Investig 12(2):234–243. https://doi.org/10.1111/jdi.13337CrossRefPubMed

Title: The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men
Authors: Miaomiao Jin
Renjun Cao
Pengfei Shan
Xiaohong Niu
Publication date: 01-12-2023
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Published in: Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01237-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in men

Abstract

Summary

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials

The effect of patient positioning on measurements of bone mineral density of the proximal femur: a simulation study using computed tomographic images

Network analysis of osteoporosis provides a global view of associated comorbidities and their temporal relationships

Older adults physically inactive in occupational and commuting domains have a higher risk for osteopenia and osteoporosis: A 12-month prospective study

The integrated structure of care: evidence for the efficacy of models of clinical governance in the prevention of fragility fractures after recent sentinel fracture after the age of 50 years

Frequency of osteoporosis in Chinese patients with rheumatoid arthritis: a meta-analysis